Identification of Three Species of Borrelia burgdorferi Sensu Lato (B. burgdorferi Sensu Stricto, B. garinii, and B. afzelii) Among Isolates from Acrodermatitis Chronica Atrophicans Lesions  by Picken, Roger N. et al.
Identification of Three Species of Borrelia burgdorferi Sensu Lato
(B. burgdorferi Sensu Stricto, B. garinii, and B. afzelii) Among
Isolates from Acrodermatitis Chronica Atrophicans Lesions
Roger N. Picken,* Franc Strle,† Maria M. Picken,‡* Eva Ruzic-Sabljic,§ Vera Maraspin,† Stanka Lotric-Furlan,†
and Joze Cimperman†
*Research Service, Hines Veterans’ Administration Hospital, Maywood, Illinois, U.S.A.; †Department of Infectious Diseases, University Medical Center,
Ljubljana, Slovenia; †Department of Pathology, Loyola University Medical Center, Maywood, Illinois, U.S.A.; §Institute of Microbiology, University of
Ljubljana, Ljubljana, Slovenia
In Europe, at least three species of Borrelia are known to
be causative agents of Lyme borreliosis: B. burgdorferi sensu
stricto, B. garinii, and B. afzelii. Observable differences in
the molecular characteristics of the three species have led
to speculation that they may also differ in their pathogenic
potential and/or tissue tropisms. Several studies have
found an association between the chronic skin manifesta-
tion of Lyme borreliosis, acrodermatitis chronica atro-
phicans, and infection by B. afzelii. We sought to find
further evidence for such a correlation by studying the
genetic profiles of 22 strains of B. burgdorferi sensu lato
derived from 21 patients who presented to the University
Medical Center, Ljubljana, Slovenia between 1992 and
1995. Strains were isolated in culture from skin biopsies
of acrodermatitis chronica atrophicans lesions; in the
case of one patient two separate acrodermatitis chronica
atrophicans lesions were cultured. All 21 patients had
Acrodermatitis chronica atrophicans (ACA) is a late cuta-neous manifestation of Lyme borreliosis characterized byerythrocyanotic lesions that typically involve acral sites(Åsbrink and Hovmark, 1987, 1988; Abele and Anders,1990). Untreated disease has a long progressive course
that comprises both inflammatory and atrophic stages where the
evolution of lesions is slow and insidious. In the atrophic phase,
generalized thinning of the dermis and epidermis gives the skin a
transparent appearance, often with clearly visible veins (Abele and
Anders, 1990; Åsbrink, 1993). Unlike other skin manifestations, such
as erythema migrans and borrelial lymphocytoma, ACA does not heal
without treatment; the inflammatory stage may last for months or years
and the atrophic stage can endure for decades (Åsbrink, 1993). The
borrelial etiology of the disease was firmly established in 1984 by the
cultivation of Borrelia burgdorferi from an ACA lesion (Åsbrink et al, 1984).
Within the general taxon B. burgdorferi sensu lato, three species are
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clinically typical lesions with ‘‘classic’’ histopathology
and high IgG antibody titers to B. burgdorferi sensu lato.
Strains were characterized and typed by 16S ribosomal
RNA-specific polymerase chain reaction and determina-
tion of their large restriction fragment patterns using
pulsed-field gel electrophoresis of MluI-digested genomic
DNA. Of the 22 isolates studied, 17 possessed the highly
conserved MLa1 pattern characteristic of B. afzelii. The
remaining five isolates possessed large restriction frag-
ment patterns that were typical of B. garinii (MLg2, four
isolates from three patients) and B. burgdorferi sensu stricto
(MLb2, one isolate). The results of 16S ribosomal RNA-
specific polymerase chain reaction were concordant with
these species designations. These data show that B. afzelii
is the predominant, but not the exclusive, etiologic
agent of acrodermatitis chronica atrophicans. Key words:
molecular characterization/patient isolates. J Invest Dermatol
110:211–214, 1998
known to be causative agents of human Lyme borreliosis: B. burgdorferi
sensu stricto, B. garinii, and B. afzelii (Baranton et al, 1992). There is
disparity in their geographic distribution, however; whereas all three
species have been encountered among European patient isolates, only
B. burgdorferi sensu stricto has thus far been isolated from patients in
North America. These findings have led to speculation that the unequal
distribution of species might be associated with perceived differences in
disease manifestations. For example, ACA has been widely encountered
throughout Europe, but there have been few reports from the United
States. Of 45 cases of ACA seen at the Mayo Clinic up to 1945, only
six patients were born in the United States, and the remainder were
immigrants, mostly from Europe (Montgomery and Sullivan, 1945).
Since then, only a few additional reports from North America have
appeared (Steere et al, 1986; Lavoie et al, 1986; Tuffanelli, 1987;
Kaufman et al, 1989; Edwards et al, 1992).
Such observations have led to a search for associations between
individual Borrelia spp. and the clinical manifestations of Lyme borre-
liosis. In the case of ACA, indications of just such a correlation were
found. Molecular studies of ACA isolates or sera from several European
countries over the last 4 y have produced evidence suggesting an
exclusive association of B. afzelii with ACA (van Dam et al, 1993;
Assous et al, 1993; Anthonissen et al, 1994; Balmelli and Piffaretti,
1995; Wienecke et al, 1995; Ohlenbusch et al, 1996). To further
investigate this phenomenon, we examined 22 new isolates of B. burg-
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Table I. Borrelia spp. and strains used and results of molecular subtyping studies
Species Strain designation LRFPa Biologic origin Geographic location
Reference strains
DN127 genomic group DN127 U Tick (Ixodes pacificus) U.S.A.
DN127 genomic group 25015 U Tick (Ixodes scapularis) U.S.A.
B. burgdorferi sensu stricto B31 [ATCC 35210] MLb1 Tick (Ixodes scapularis) U.S.A.
B. burgdorferi sensu stricto 297 [ATCC 53899] MLb2 CSFb U.S.A.
B. garinii 20047 MLg1 Tick (Ixodes ricinus) France
B. garinii PBi MLg2 CSF Germany
B. afzelii VS461 MLa1 Tick (Ixodes ricinus) Switzerland
VS116 genomic group VS116 U Tick (Ixodes ricinus) Switzerland
Strains from patients
B. burgdorferi sensu stricto SL-91 MLb2 Skin (ACAc) Slovenia
B. garinii SL-92 MLg2 Skin (ACA) Slovenia
B. garinii SL-95 MLg2 Skin (ACA) Slovenia
B. garinii SL-109 MLg2 Skin (ACA) Slovenia
B. afzelii SL-94 MLa1 Skin (ACA) Slovenia
B. afzelii SL-112 MLa1 Skin (ACA) Slovenia
aLRFP, large restriction fragment pattern. Nomenclature follows the system devised previously (Belfaiza et al, 1993) for bands .70 kb in size. Thus, all LRFP derived from restriction
endonuclease Mlu I digestion are designated ML, B. burgdorferi sensu stricto LRFP are designated MLb, B. garinii LRFP are designated MLg, and B. afzelii LRFP are designated MLa. U,
undesignated LRFP.
bCSF, cerebrospinal fluid.
cACA, acrodermatitis chronica atrophicans.
dorferi sensu lato derived from Slovene patients with ACA lesions. This
report presents data on the molecular subtyping of these strains.
MATERIALS AND METHODS
Patients All patients presented to the University Medical Center, Lubljana,
between July 1992 and June 1995. Criteria for the inclusion of patients in the
study were as follows: (i) they had not received antibiotic treatment specifically
for ACA, (ii) they had typical lesions on the extremities, (iii) histopathologic
findings supported the diagnosis of ACA, (iv) IgG antibody titers against B.
burgdorferi sensu lato were detectable, and (v) B. burgdorferi sensu lato was isolated
in culture from a skin biopsy.
Skin biopsies and cultures Skin biopsies were taken from areas where the
ACA lesions were most prominent. In the case of one patient two separate
ACA lesions were cultured. Methods pertaining to the excision of tissue, the
inoculation into growth medium, and the isolation of strains have been described
previously (Strle et al, 1995a). In some patients lumbar puncture was also
performed and cerebrospinal fluid (CSF) cultured for B. burgdorferi sensu lato.
Standard microbiologic techniques were employed to preclude the possibility
of cross-contamination of cultures. Representative B. burgdorferi sensu lato isolates
obtained from ACA lesions of patients are listed in Table I along with reference
strains used in comparative studies. All patient strains used in this study were
low passage isolates.
Antibodies to B. burgdorferi sensu lato For all patients IgM and IgG antibody
titers against B. burgdorferi sensu lato were determined on the day of skin biopsy
by immunofluorescence assay (Wilske et al, 1984). A local isolate of B. afzelii
was used as antigen. Titers of 1:256 or higher were interpreted as positive.
Species identification Isolates were identified to the species level using two
independent methods: (i) 16S ribosomal RNA (rRNA)-specific polymerase
chain reaction (PCR), (ii) large restriction fragment pattern (LRFP) analysis
involving cleavage of genomic DNA with the restriction enzyme MluI and
separation of the fragments using pulsed-field gel electrophoresis. Well-character-
ized reference strains of B. burgdorferi sensu lato were included for comparison
(Table I). The strains B31, 20047, and VS461 are the type strains of the species
B. burgdorferi sensu stricto, B. garinii, and B. afzelii, respectively. Isolates representing
other genomic groups of B. burgdorferi sensu lato included strains DN127 and
25015 (DN127 group), and VS116 (VS116 group). The LRFP produced by
restriction enzyme digestion are characteristic of each species (Belfaiza et al,
1993). Both techniques were performed as described previously (Strle et al,
1995a,b; Picken et al, 1995, 1996).
RESULTS
Patients From July 1992 to June 1995, 104 Slovene patients pre-
senting with ACA were biopsied and cultured for B. burgdorferi sensu
lato. In one of the patients two separate lesions were biopsied. Twenty-
four lesions from 23 patients grew spirochetes, for an overall isolation
Table II. Frequency of isolation of Borrelia spp. from
acrodermatitis chronica atrophicans lesions
Species LRFP No. of isolates obtained
B. burgdorferi sensu stricto MLb2 1
B. garinii MLg2 4a
B. afzelii MLa1 17
aTwo isolates were obtained from separate ACA lesions of one patient.
rate of 22%. In addition, spirochetes were concomitantly isolated from
the CSF of one patient. Twenty-two ACA isolates from 21 patients
were subsequently studied by molecular subtyping methods. The
patients comprised 14 females (67%) and seven males (33%), aged 21–
76 y (median 66 y). The duration of ACA lesions varied from 5 mo
to more than 20 y (median 2 y). Eighteen of the 21 patients recalled
one or more tick bites in the preceding years and seven patients had
a prior recollection of erythema migrans, which occurred on the
same extremity as the subsequent ACA lesion in five patients. By
immunofluorescence assay, all 21 patients had an IgG antibody response
to B. burgdorferi sensu lato, and four also demonstrated an IgM response.
16S rRNA-specific PCR PCR analysis of the 22 isolates indicated
that 17 isolates were B. afzelii, four were B. garinii, and one was
B. burgdorferi sensu stricto (Table II). In one patient, where isolates were
obtained from two separate ACA lesions, both strains typed as B. garinii.
Figure 1 shows the results of PCR amplification of DNA from six
patient ACA isolates: B. burgdorferi sensu stricto strain SL-91, B. garinii
strains SL-92, SL-95, and SL-109, and two representatives (SL-94, SL-
112) from the 17 B. afzelii isolates. Only one of the two B. garinii
isolates obtained from the same patient is shown (SL-95). Eight well-
characterized reference strains, representing the DN127 genomic group,
B. burgdorferi sensu stricto, B. garinii, B. afzelii, and the VS116 genomic
group, are shown for comparison. Note, however, that the 16S rRNA-
specific PCR primers are not able to differentiate B. garinii from the
VS116 genomic group (Fig 1).
LRFP analysis Figure 2 shows the results of LRFP analysis of the
same six representative patient ACA isolates and the eight reference
strains used in Fig 1. In all cases, results from the two methods of
species identification were concordant. Seventeen of the 22 isolates
typed as B. afzelii, possessing the same MLa1 LRFP as VS461, the
B. afzelii type strain; this LRFP is characterized by fragments of µ440,
320, and 90 kb (Picken et al, 1996). Four isolates typed as B. garinii,
possessing the same MLg2 LRFP as the B. garinii reference strain PBi;
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Figure 1. Molecular subtyping of patient ACA isolates by 16S rRNA-
specific PCR. Genomic DNA from six representative ACA patient isolates
and eight reference strains of B. burgdorferi sensu lato were amplified in PCR
reactions using 16S rRNA primer sequences specific for B. burgdorferi sensu
stricto, B. garinii, and B. afzelii. Amplification products were applied to an
agarose gel with three sets of sample-loading wells, electrophoresed for 2.5 h,
stained with ethidium bromide, and photographed using ultraviolet
transillumination. Horizontal lines show the position of sample wells loaded
with PCR products generated using: (A) B. burgdorferi sensu stricto-specific
primers; (B) B. garinii-specific primers; (C) B. afzelii-specific primers. Strain
designations are shown above their respective lanes (refer to Table I for the
species designation of reference strains). Lane M contains molecular size markers
(concatenates of a 123 bp fragment). Only two (SL-94, SL-112) of 17 isolates
that typed as B. afzelii are shown, as representative examples.
this LRFP is characterized by fragments of µ390, 220, 100, and 80 kb
(Picken et al, 1996). Three of the B. garinii patient isolates are shown
in Fig 2 (SL-92, SL-95, and SL-109). In one patient, where two
isolates were obtained from separate ACA lesions, only one of the two
strains is shown in Fig 2 (SL-95), because both isolates produced
identical macrorestriction patterns. One isolate (SL-91) typed as B. burg-
dorferi sensu stricto, possessing the same MLb2 LRFP as B. burgdorferi
sensu stricto reference strain 297; this LRFP is characterized by fragments
of µ410, 160, 140, and 110 kb (Picken et al, 1996).
DISCUSSION
The 21 patients and 22 isolates described in this report represent the
largest series of new, consecutive ACA patients and strains studied to
date. Previously, the largest number of ACA patients investigated was
represented by the 18 lesional skin biopsies studied by Wienecke et al
(1995), from all of which B. afzelii-specific sequences were amplified
by PCR. In contrast to their results, we found that four isolates typed
as B. garinii and one isolate typed as B. burgdorferi sensu stricto. This is
the second report of an association between B. burgdorferi sensu stricto
and ACA; previously, the Danish isolate DK7, which was described as
being derived from an ACA lesion, was typed as B. burgdorferi sensu
Figure 2. Molecular characterization of patient ACA isolates and
reference strains by pulsed-field gel electrophoresis. Late logarithmic phase
cells from the same six representative ACA patient isolates and eight reference
strains shown in Fig 1 were embedded in plugs of low melting temperature
agarose and processed to lyse spirochetes. Slices from plugs were digested with
restriction enzyme MluI and loaded into the slots of a pulsed-field gel
electrophoresis gel. After electrophoresis for 24 h in a pulsed-field apparatus,
the gel was stained with ethidium bromide and photographed using ultraviolet
transillumination. Strain designations are shown above their respective lanes
(refer to Table I for the species designation of reference strains). Lane M
contains molecular size markers (λDNA concatamers of 48.5–485 kb). Only
two (SL-94, SL-112) of 17 isolates that typed as B. afzelii are shown, as
representative examples.
stricto by an Outer Surface Protein A serotyping method (Wilske
et al, 1993).
To date, only one, highly conserved LRFP (MLa1) has been
described for B. afzelii (Belfaiza et al, 1993; Strle et al, 1995b; Picken
et al, 1996). In this study, 17 of 22 isolates investigated possessed this
MLa1 LRFP, demonstrating that they belong to the species B. afzelii.
Six LRFP have been described for B. garinii (Belfaiza et al, 1993; Strle
et al, 1995b; Picken et al, 1996), of which four have been encountered
among Slovene patient isolates and six among Slovene tick isolates
(Strle et al, 1995b; Picken et al, 1996). The four B. garinii strains
isolated from ACA lesions in this study all possessed the MLg2 LRFP.
This was also found to be the most prevalent B. garinii LRFP isolated
from patients and ticks in Slovenia (Strle et al, 1995b; Picken et al,
1996) and may not therefore reflect a particular association with ACA.
PBi, the MLg2 reference strain used in this study, was isolated from
the CSF of a patient residing in Germany (Wilske et al, 1993). It would
therefore seem that B. garinii of this type can be responsible for at least
two of the sequelae of Lyme borreliosis, neuroborreliosis, and ACA.
Of the three species that infect humans, B. burgdorferi sensu stricto has
been shown to be the most heterogeneous in terms of number of
LRFP (Belfaiza et al, 1993; Strle et al, 1995b; Picken et al, 1996). The
single B. burgdorferi sensu stricto isolate that we obtained from ACA
possessed the MLb2 LRFP; previously, we have also encountered this
LRFP among isolates derived from erythema migrans lesions of Slovene
patients (Picken et al, 1996). Borrelia burgdorferi sensu stricto reference
strain 297 (ATCC 53899), which also possesses the MLb2 LRFP, was
isolated from the CSF of a North American patient. This suggests not
only that strains of this type can be responsible for both neuroborreliosis
and ACA, but also that the potential for ACA is present in North
America.
The paucity of case reports from the United States has resulted in
ACA being generally regarded as a ‘‘European’’ manifestation of chronic
Lyme borreliosis; however, there have been sporadic reports of ACA
from the United States over several years (Steere et al, 1986; Lavoie
et al, 1986; Tuffanelli, 1987; Kaufman et al, 1989; Edwards et al, 1992).
Recently, detailed case reports have been published of patients from
New York who had clinically classic lesions and/or elevated serum
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antibody titers to B. burgdorferi with demonstration of spirochetes by
antibody staining (Kaufman et al, 1989; Edwards et al, 1992). The fact
that B. burgdorferi sensu stricto has now been found associated with ACA
lesions (Wilske et al, 1993; this study) supports the notion that cases of
ACA can occur in the United States; however, reasons for its low
incidence remain obscure.
Alternatively, it has also been shown that patients can be concomit-
antly infected with more than one Borrelia spp. (Demaerschalk et al,
1995). Thus, it is conceivable that the ACA lesions from which the
B. garinii and B. burgdorferi sensu stricto isolates derived could actually
have been caused by a concomitant B. afzelii infection, and that in vitro
culture favored the outgrowth of B. garinii and B. burgdorferi sensu
stricto. This possibility cannot be ruled out; however, it can be concluded
that these latter species were present in the ACA skin lesion at the
time of biopsy. Also, in the case where two isolates were obtained
from separate ACA lesions of one patient, both strains had identical
molecular properties (B. garinii, MLg2 subclass). In the case of another
patient, isolates were obtained from both an ACA lesion and CSF;
both strains typed as B. afzelii MLa1 (data not shown).
We conclude from these findings that in Slovene patients B. afzelii
is not the sole etiologic agent of ACA and that this chronic skin
manifestation can also result from infection with B. garinii and
B. burgdorferi sensu stricto. The finding of involvement by the latter
species suggests that the potential for ACA also exists in North America,
and recent case reports from the United States appear to support this.
It remains to be determined why a higher incidence of ACA is seen
among Lyme borreliosis patients in Europe than in North America.
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